首页> 外文期刊>Journal of pharmaceutical sciences. >Development of a recursive finite difference pharmacokinetic model from an exponential model: application to a propofol bolus.
【24h】

Development of a recursive finite difference pharmacokinetic model from an exponential model: application to a propofol bolus.

机译:从指数模型开发递归有限差异药代动力学模型:应用于丙泊酚丸剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Propofol is commonly administered, as a single bolus dose, for the induction of general anesthesia. The purpose of this study was to mathematically assess the ability to model propofol induction-dose serum levels with a recursive finite difference equation (RFDE). Using data obtained from a prior published study, propofol induction pharmacokinetics were accurately modeled, on a subject-specific basis, with a third-order homogeneous finite difference equation with constant coefficients: P((k + 3)) = AP((k + 2)) + BP((k + 1)) + CP((k)). Furthermore, each RFDE model is derived directly from the coefficients of a traditional three-compartment pharmacokinectic exponential equation. Based on this study, third-order RFDE models can have identical accuracy as three-compartment exponential models. In this particular application, it should be noted that each RFDE model required only three coefficients whereas each exponential model required six. Also, there was overall less patient-to-patient variability of the coefficients of the RFDE models. In general, it appears that RFDE models uniquely allow for predicting subsequent drug levels from preexisting ones. However, RFDE models require initial conditions whereas exponential models do not. Additional studies and applications of exponentially-derived RFDE pharmacokinetic models may be warranted.
机译:丙泊酚通常以单次大剂量给药,以诱导全身麻醉。这项研究的目的是通过递归有限差分方程(RFDE)在数学上评估对异丙酚诱导剂量血清水平建模的能力。使用从先前发表的研究中获得的数据,在受试者特定的基础上,使用具有恒定系数的三阶齐次有限差分方程精确建模丙泊酚诱导药代动力学:P((k + 3))= AP((k + 2))+ BP((k + 1))+ CP((k))。此外,每个RFDE模型都是直接从传统的三室药动学指数方程式的系数导出的。根据这项研究,三阶RFDE模型可以具有与三格指数模型相同的准确性。在此特定应用中,应注意,每个RFDE模型仅需要三个系数,而每个指数模型则需要六个系数。而且,RFDE模型的系数总体上因人而异。通常,RFDE模型似乎可以唯一地预测现有药物的后续药物水平。但是,RFDE模型需要初始条件,而指数模型则不需要。可能需要对指数衍生的RFDE药代动力学模型进行其他研究和应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号